The principal aim of this work was to study the formulation of a ternary complex comprising 12 salmon calcitonin (sCT), hyaluronate (HA) and chitosan (CS) in a nanoparticle (NP) format. 13
Introduction 38
Salmon calcitonin (sCT) is commercially available as an injectable and in a nasal 39 spray form (Guggi et al., 2003) . It is indicated for the treatment of bone diseases, e.g. 40 osteoporosis, Paget's disease and bone metastasis (Guggi et al., 2003; Makhlof et al., 2010) . 41 sCT is also a promising candidate to be used in osteoarthritis (OA) (Manicourt et al., 2005) 42 and in combined therapy with alendronate in patients with rheumatoid arthritis (RA) (Ozoran 43 et al., 2007) . 44
It has been reported that a major issue associated with development of efficient intra-45 articular (IA) delivery systems is the rapid clearance of many compounds from the joint 46 (Morgen et al., 2013) . Therefore it is desirable that such IA systems have a longer duration of 47 action to minimise the number of injections due to the discomfort and pain associated with 48 administration as well as possible risk of infection (Gerwin et al., 2006) . A range of 49 particulate carriers have been investigated to achieve this goal, including liposomes, 50 microparticles (MPs) and nanoparticles (NPs) (Morgen et al., 2013) . The use of MPs and 51
NPs, e.g. albumin-or poly(lactic-co-glycolic acid) (PLGA)-based systems has been 52 investigated (Gerwin et al., 2006) . Horisawa et al., (2002) described that PLGA NPs should 53 be more suitable for the delivery into the inflamed synovial tissue than MPs due to their 54 ability to penetrate synovium. PLGA-based particles can provide local therapy actions in 55 joint diseases in a different manner depending on the particle size (Horisawa et al., 2002) . 56 Other examples of sCT sustained release systems, but not indicated for IA delivery, include 57 monolithic depot formulations prepared using lactide:glycolide copolymers (Millest et al., 58 9 mixtures (HA, sCT/HA, CS and sCT/CS) were lyophilised as described previously (Umerska 161 at el., 2012) and analysed using a Nicolet Magna IR 560 E.S.P. FTIR spectrophotometer. KBr 162 discs with a 1% w/w sample loading were prepared by compression (4 bar for 1 minute). 163
Accumulation of 64 scans and resolution of 2 cm -1 was used to obtain good quality spectra 164 (Paluch et al., 2010) . sCT was analysed as supplied. 165
Separation of non-associated sCT, association efficiency and peptide loading 166
Non-associated sCT was separated from NPs by a combined ultrafiltration-167 centrifugation technique (Centriplus YM-50, MWCO of 50 kDa, Millipore, USA) as 168 described earlier (Umerska et al., 2014) . A total of 5 ml of sample were placed in the sample 169 reservoir (donor phase) of the centrifugal filter device and centrifuged for 1 hour at 3000 rpm. 170
After centrifugation the volume of the solution in the filtrate vial (acceptor phase) was 171 measured and the filtrate was assayed for the content of sCT by high-performance liquid 172 chromatography (HPLC) as described in Section 2.3.7. This quantity of sCT was referred to 173 as the non-associated sCT. 174
The NP suspension from the sample reservoir was made up to 5 ml with deionised 175 water. 0.75 ml of the NP suspension from the sample reservoir was mixed with a predefined 176 volume of 0.1 mM NaOH (this NaOH concentration was optimised and did not cause sCT 177 degradation) to break up the NPs to release sCT and centrifuged for 30 minutes at 13,000 178 rpm. The supernatant was assayed for sCT content by HPLC (section 2.3.7). The rest of 179 dispersion from the sample reservoir was analysed for signs of aggregation/destruction (by 180 measuring mean particle size, zeta potential and transmittance). 181
The association efficiency (AE) and peptide loading (PL) were calculated with the use 182 of the following equations: 183 ˜H = Ӛ ӛ * 100% (Eq. 2) 186 where C is the total weight of all the components of NPs (the associated sCT and the mass of 187 HA and CS used for the preparation of NPs). 188
Release studies 189
Aliquotes of 250 µl of NPs were added to 2.25 ml of phosphate buffered saline (PBS, 190 pH=7.4). Samples were incubated at 37 ºC at 100 cpm in a reciprocal shaking water bath 191 model 25 (Precision Scientific, India). After 1, 2, 4, 6 and 24 hours 2.5 ml aliquots were 192 withdrawn and the released sCT was separated as described in Section 2.3.5. The samples 193 were centrifuged at 4500 rpm for 15 minutes. After centrifugation the volume of the solution 194 from the filtrate vial (acceptor phase) was measured and the filtrate was assayed for the 195 content of sCT by HPLC (released sCT, Section 2.3.7). The NP suspension from the sample 196 reservoir was made up to 2.5 ml with PBS and returned to the water bath to continue the 197 release studies. 198
The data from release studies were fitted to the first order equation: 199
where W is the amount of the peptide released at time t (based on cumulative release), W ∞ is 201 the amount of the peptide released at infinity and k is the release rate constant (Corrigan et 202 al., 2006) . 203
Quantification of sCT 204
Analysis of sCT content was performed using the HPLC system as described earlier 205 (Umerska et al., 2014) . Briefly, standard solutions of sCT (1.5-50 µg/ml) were prepared in 206 pH 7.4 the peptide is expected to carry an overall charge of approximately 3+ (Epand et al., 236 1983) . HA, on the other hand, with pKa of its carboxylic groups of 2.9 (Lapčik et al., 1998), 237 bears a negative charge. As the protonated amino groups of proteins may associate with the 238 de-protonated groups of anionic polysaccharides (de Kruif et To examine the possibility of sCT-polysaccharide complex formation, FTIR analysis 245 was performed on sCT/HA and sCT/CS mixtures, prepared at a polysaccharide/sCT mass 246 mixing ratio (MMR) of 0.65 (sample preparation is described in Section 2.3.4). The 247 molecular weight of HA was 257 kDa (HA257), as this was found to be the optimum in the 248 preparation of most of HA/CS NPs (Umerska et al., 2012) . Fig. 1 shows the spectra 249 (fingerprint region 650-1800 cm -1 ) along with the assignment of principal absorption groups. 250 Spectra of sCT/HA and sCT/CS systems were dominated by the absorption features of the 251 polysaccharides even though sCT contributed a larger proportion of weight in the samples. 252
Most changes in the FTIR spectra were observed in the region of vibrations associated with 253 the 1,4-glycosidic ring of the polymers (950-1200 cm -1 ) implying some hydrophobic 254 interactions between sCT and the polymers (Sharon, 2006 measurements were performed to examine if NPs were formed. Although the measured 273 particle size was 88±25 nm, the polydispersity index was high (0.65±0.19). Also, the zeta 274 potential value was relatively low, -11.6±2.17 mV, indicating that although NPs were 275 formed, they did not have good physical stability. The CMR appeared to be the main factor 276 influencing the type of HA257/sCT dispersion. For CMRs greater than 1 (1.42 and 2. Having observed that the precipitate formed when mixing HA257 and sCT solutions 292 at low MMR values was soluble in HA solution and that the formation of precipitate was 293 composition dependent, it was hypothesised that a soluble complex may also be formed. This 294 was investigated by measuring the dynamic viscosity (DV) of HA257 solution without and 295 with addition of sCT. After dissolving sCT in the HA257 solution the DV decreased 296 significantly (p<0.05) compared to the control (HA257 solution without sCT) (Fig. 2a) . The 297 change in the DV values provides a confirmation that a soluble complex between HA257 and 298 sCT was formed. Interestingly, when sCT was dissolved in CS solution, the appearance of the 299 system did not change and the DV values of CS/sCT solutions did not differ from the 300 reference (CS solution without sCT) (Fig. 2b ) for all CS concentrations tested. 301
In conclusion, infrared studies are consistent with the presence of hydrophobic 302 interactions between sCT and CS and sCT and HA. In the latter binary system there was 303 evidence of electrostatic interactions. sCT and HA appears to exhibit associative phase 304 separation as concluded from dynamic viscosity, transmittance and particle size data, 305 however only at certain HA257/sCT MMR values. Therefore, for studies involving formation 306 of HA257/CS/sCT systems, the HA257/sCT MMR ratio was always kept above 0.7 (Table 2) the species (due to solution pH and specific intermolecular interactions) and increase peptide 310 loading. were prepared. In most cases stable, non-sedimenting (within 24 hours or longer) NPs were 323 formed, however in formulations containing the highest concentration of sCT (1 mg/ml) and 324 HA257/CS MMRs of 2.5 and 5 (sample S15 and S14, respectively, Table 2 ) immediate 325 aggregation was observed. Furthermore, in the formulation with sCT concentration of 0.5 326 mg/ml and HA/CS MMR of 2.5 (sample S12, Table 2 ) precipitation was observed after a few 327 hours of storage at room temperature. All samples showing physical instability were 328 characterised by a CMR close to 1 (CMRs of 1.15, 1.26 and 0.94 for S12, S14 and S15, 329 respectively). 330
The next step was incorporation of high amounts of sCT (0.5 and 1.0 mg/ml) into NPs 331 with 2 mg/ml TPC and the same HA257/CS MMRs (2.5, 5 and 10). All formulations based 332 on HA257/CS MMRs of 5 and 10 were physically stable, no sedimentation was observed up 333 to 24 hours. In contrast to 1 mg/ml TPC NPs, the 2 mg/ml TPC-based formulation with aHA257/CS MMR of 2.5 was physically stable and it was necessary to increase the 335 concentration of sCT to 1 mg/ml to cause aggregation (sample S22, Table 2 ). Therefore the 336 main factor determining the physical stability of HA257/CS/sCT NPs is not the HA/CS 337 mixing ratio, but the mixing ratio of the three constituents. For instance, for HA257/CS NPs 338 with MMR of 2.5 (TPC of 1 mg/ml), aggregation was observed for the HA257/CS/sCT 339 formulation with an MMR of 2.5/1/1.75 (sample S12), while the formulation with TPC of 2 340 mg/ml and sCT of 0.5 mg/ml (a HA257/CS/sCT MMR of 2.5/1/0.87, sample S19) was stable. 341 This is consistent with the CMR of sample S12 being closer to 1 (CMR=1.15) in comparison 342 to sample S19 (CMR=1.27) and, when the concentration of sCT was increased to 1 mg/ml 343 (sample S22), the CMR decreased to 1.11 and aggregation was observed. As the measurements of transmittance and viscosity confirmed the formation of a 354 binary HA257/sCT complex, these parameters were also measured for ternary 355 HA257/CS/sCT systems. Transmittance values, which give information on the turbidity of 356 samples, depend on the concentration and the particle size of NPs (Umerska et al., 2014) . 357
Transmittance of all 1 mg/ml TPC-based formulations decreased gradually with an increaseconcentration was also observed for HA257/CS formulations with MMRs of 5 and 10 ( Fig.  361 3). Similar to the binary HA257/sCT systems, the CMR influenced turbidity of the ternary 362 HA257/CS/sCT systems at the lower TPC (1 mg/ml). Samples with a CMR greater than 2 363 were transparent and a further decrease in the CMR from approximately 2 to 1.24 resulted in 364 a dramatic increase in turbidity of the samples. In contrast to NPs with a TPC of 1 mg/ml, it 365 was seen that when the TPC was increased to 2 mg/ml, the transmittance values of the 366 systems tested were not statistically significantly (p<0.05) different (Fig. 3) . It can be 367 concluded that, in addition to effects of the HA257/CS MMR and TPC on dispersion 368 turbidity, incorporation of sCT has also an influence on transmittance. Rising turbidity values 369 corresponding to an increase in the sCT concentration may indicate that the binary complex 370 between sCT and HA did not fully dissociate after addition of CS and the peptide was 371 incorporated in the NPs. FTIR spectrum of a HA257/CS/sCT system (sample S9) was 372 dominated by absorption groups characteristic of the HA257/sCT complex ( It was seen for each HA257/CS MMRs and TPCs tested that inclusion of sCT 377 decreased the dynamic viscosity of the dispersions significantly (Fig. 4) . The higher the dose 378 of sCT, the lower the dynamic viscosity of the liquid. This decrease in viscosity was the 379 greatest for formulations with a HA257/CS MMR of 10 and the smallest for a HA257/CS 380 (2012), the increased viscosity of colloidal dispersions compared to water may be attributed 382 to the free polymer present in the liquid. In all formulations tested here HA is believed to be 383 in excess and present either as free or loosely polymer bound to NP surfaces. As the NPsthemselves are not expected to have negligible effect on the viscosity (Philip et al., 1989) , 385 HA appears to be the main factor determining the viscosity of the dispersions examined. As 386 presented above, the interaction between HA and sCT resulted in a decrease in the dynamic 387 viscosity of the liquid system and it may contribute to the decreased viscosity of the 388 HA257/CS dispersions. 389
In summary, the lower transmittance and viscosity values of ternary HA257/CS/sCT 390 systems compared with the binary HA257/CS samples confirm that in the ternary systems 391 interactions between sCT and HA are still present despite the competition between the positively 392 charged groups of CS and sCT for binding with the negatively charged groups of HA. 393
All HA257/CS NPs containing sCT were characterised by a small particle size, the 394 diameter of the particles was between 148±4 nm (TPC of 1 mg/ml; HA257/CS MMR of 5 395 and sCT of 0.35 mg/ml) and 229±28 nm (TPC of 1 mg/ml; HA257/CS MMR of 2.5 and sCT 396 of 0.35 mg/ml) ( The incorporation of sCT decreased the diameter of the particles at HA257/CS MMRs of 405 5 and 10 (Fig. 5) . A different behaviour was observed for formulations with a TPC of 1 mg/ml 406 and a HA257/CS MMR of 2.5 -employing up to 0.2 mg/ml sCT did not change the particle 407 size significantly, however a further increase in sCT concentration (to 0.35 mg/ml) resulted inwithout sCT. When a TPC of 2 mg/ml was employed to formulate NPs, only some of the sCT 410 concentrations tested were seen to have an impact of the NP size (Fig. 5) . 411
The increase in turbidity of NPs with a TPC of 1 mg/ml and containing larger 412 amounts of sCT (Fig. 3) , despite a decrease in the particle size (Fig. 5) , suggests that more 413 particles were formed in comparison to sCT-free NPs. An increase in the particle size of NPs 414 with a TPC of 1 mg/ml, a HA257/CS MMR of 2.5 and sCT of 0.35 mg/ml was observed 415 (sample S9, Table 2 , Fig. 5 ). This formulation contains a relatively small excess of HA in 416 relation to CS and sCT and it is possible that repulsion between the positively charged 417 constituents in this sample (S9) due to their relatively smaller degree of neutralisation by 418 negative charges of HA may be responsible for the increased particle size. 419
All NPs containing sCT were characterised by a narrow size distribution as the PDI 420 values were in the range between 0.072±0.035 (TPC of 1 mg/ml, HA257/CS MMR of 2.5, 421 sCT of 0.35 mg/ml) and 0.246±0.037 (TPC of 2 mg/ml, HA257/CS MMR of 10, sCT of 0.5 422 mg/ml) (Fig. 6) . NPs with larger amounts of sCT were generally characterised by lower 423 polydispersity than HA257/CS NPs without sCT (Fig. 6) . The PDI values of HA257/sCT 424 binary complexes were markedly higher than those observed for HA257/CS NPs or 425 HA257/CS/sCT NPs. When making a ternary system composed of HA, CS and sCT it is 426 possible that due to component interactions, in addition to a HA/CS/sCT complex, also 427 HA/CS and HA/sCT NPs may form. The low PDI values observed for HA257/CS/sCT 428 systems show that more uniform in size NPs formed and it is more likely to have only one 429 type of the particles present -HA257/CS/sCT NPs. 430
All NPs tested had negative surface charge despite loading sCT into the particles (Fig.  431   7) . A gradual increase in the zeta potential values was associated with the increase in sCT 432 concentration used for prepare NPs. Nevertheless, most of the dispersions were characterised20 good physical stability. A statistically significant decrease in the surface charge can also be 435 linked to a decrease in the HA257/CS MMR and the TPC (Fig. 7) . A linear relationship was 436 found when the zeta potential values were plotted as a function of CMR for both TPCs (R 2 of 437 0.9397 and 0.9644 for a TPC of 1 mg/ml and 2 mg/ml, respectively). 438
As shown in Table 2 , the ratio of ionisable carboxylic groups in HA molecules to 439 ionisable amino groups in CS molecules does not correspond to the mass mixing ratio, as 440 both polymers have different charge density. As the actual number of the ionised groups also 441 depends on the environmental pH, HA (pKa 2.9) can be considered as fully dissociated at pH 442 experimental results show that samples with a total n -/n + charge mixing ratio close to 1 (S12, 454 S15 and S22) were physically unstable. Interestingly, S14 (HA257/CS MMR 5, sCT 1.0 455 mg/ml) with a CMR of 1.26 was not stable, while S9 (HA257/CS MMR 2.5, sCT 0.5 mg/ml) 456 with a CMR of 1.24 was present as a stable colloidal dispersion. It may be due to the small, 457 but statistically significant difference in pH between those two formulations (Table 2) characterised by a HA/CS MMR of 5, a TPC of 1 mg/ml and sCT of 0.5 mg/ml was selected 472 due to its good physical stability, small particle size (Fig. 5) and high sCT loading (sample 473 S11, Table 2 ). Three molecular weights of HA were tested: 176 kDa (HA176), 257 kDa and 474 590 kDa (HA590). HA with a higher molecular weight was not considered due to formation 475 of macroscopic aggregates with CS (Umerska et al., 2012) . 476
Incorporation of sCT did not influence the turbidity of HA590 based formulations, 477 however the transmittance of sCT-loaded NPs with HA176 and HA257 was significantly 478 lower (77±4 and 70±8%, respectively) than their controls (NPs without sCT) (95±2 and 479 92±5%, respectively). The dynamic viscosity of dispersion containing sCT/NPs was 480 significantly lower than that of the HA/CS NP dispersion without sCT for all three HA tested 481 (Fig. 8A) . HA590-based nano-suspension containing sCT/NPs was significantly more 482 viscous in comparison to the other two formulations based on HA176 and HA257 (Fig. 8A) .lower than that of the respective controls (NPs without sCT), but only observed for HA590 485 (p=0.019) and HA257 (p=0.041) samples (Fig. 8B) . All those sCT/NPs tested had similar 486 particle sizes between 131-161 nm, which were not statistically different from each other, 487 therefore it can be concluded that the molecular weight of HA in the range of ~150-600 kDa 488 does not influence the particle size of sCT/NPs. The polydispersity index of sCT/NPs was 489 lower compared with the control samples (Fig. 8C) and NPs based on HA590 were 490 characterised by a significantly broader size distribution that NPs with HA176 and HA257. 491
The zeta potential values of the NPs were markedly higher for sCT/NPs when 492 compared to the controls (NPs without sCT) (Fig. 8D) . The difference in the zeta potential 493 value between sCT/NPs and the control without sCT was the greatest for HA590-based NPs. 494
Also, the value of zeta potential of this sample (loaded with sCT) was statistically 495 significantly different compared to those of equivalent NPs comprising HA176 and HA257 496 (p<0.01). 497
sCT association efficiency and peptide loading 498
When preparing bioactive-containing NPs, it is necessary to determine the association 499 efficiency (AE) and the bioactive loading, as they are two important NP quality control 500 parameters with substantial impact in their application (Lu et al., 2011) . Successful polymeric 501 nanocarriers should be characterised by a high loading capacity in order to reduce the amount 502 of the particles required for administration. 503
As shown in Table 2 , sCT was associated with NPs very efficiently as in all 504 formulations tested the AE values were well over 90%. Although there were statistically 505 significant differences in the groups of formulations with a HA257/CS MMR of 5 and 10 506 when different concentrations of sCT were used (e.g. the AE of the sCT 0.5 mg/ml 507 formulation was significantly lower (p=0.041) than the AE of other HA257/CS based 508 samples containing a smaller quantity of sCT), the differences were smaller than 2%, which 509
is not expected to have any practical effect on properties of formulations. It is noteworthy that 510 the formulations with the lowest AE for each HA257/CS MMR tested contained the highest 511 dose of sCT for that particular HA257 and CS particle composition. It was observed that the 512 HA257/CS MMR also had an effect on the AE of sCT in NPs. Although the difference was 513 small, NPs with a HA257/CS MMR of 2.5 always had the AE value significantly lower than 514 the two other MMRs for all concentrations of sCT tested (p=0.022, 0.001 and p<0.001 for 515 0.1, 0.2 and 0.35 mg/ml of sCT, respectively). The maximum amount of sCT which could be 516 incorporated into the particles was determined by their composition -the more HA in the 517 particles, the more sCT could be loaded in the NPs before aggregation occurred. 518
To summarise, sCT-loaded HA/CS NPs were characterised by an excellent 519 association efficiency, which were consistently above 90% for all stable formulations made 520 in contrast to HA/protamine/sCT NPs, where AE values were in the range 64-98% (Umerska 521 et al., 2014). The system with the greatest peptide loading of 49.6% was that based on a 1 522 mg/ml TPC, a HA257/CS MMR of 10 and 1 mg/ml sCT (sample S13, Table 2 The results of in vitro release studies of sCT from NPs showed that the amount of sCT 533 released within the first hour ranged between 23±4% (sample S9) and 54±4% (sample S7) 534 (Fig. 9) . The sample S9 (with 0.35 mg/ml of sCT and a HA257/CS MMR of 2.5) was 535 characterised by a markedly lower peptide release than other formulations and only 536 approximately 46% of sCT was released after 24 hours. Interestingly, this sample was made 537 of HA257 and CS at an MMR of 2.5 indicating that the content of HA in this sample was low 538 in comparison to a relatively high sCT content. In other formulations the amount of sCT 539 released after 24 hours varied between 68 and 94%. Statistical comparisons (ANOVA) 540 between the amounts of sCT released after 24 hours showed that sample S9 was different to 541 samples S5, S7, S8 and S10. 542
The data from the release studies was fitted to the first order equation (Eq. 3). The 543 parameter estimates and related statistics are summarised in Table 3 . The k parameter (release 544 rate constant) was found (by applying one-way ANOVA) to be independent of the dose of 545 sCT loaded for the MMR of 10 (p=0.778) and the MMR of 2.5 (p=0.764), but not for the 546 MMR of 5 (p=0.002). The MMR had no impact on the k parameter for NPs with 0.2 mg/ml 547 sCT (p=0.957) and 0.35 mg/ml (p=0.055) but it was significant for 0.5 mg/ml sCT (p=0.035). 548
The MMR had no impact on the W ∞ parameter (the amount of sCT released at infinity) for 549 NPs with 0.2 mg/ml sCT (p=0.058) and 0.5 mg/ml sCT (p= 0.543), but it was significant for 550 NPs with 0.35 mg/ml sCT (p<0.001). From Fig. 9 it appears that lower MMRs and higher 551 amounts of sCT in NPs resulted in lower % of sCT released at 24h. Two-way ANOVA 552 confirmed that this is, indeed, the case (p<0.001), however only the main effects (the MMR 553 and sCT content) were significant (p<0.001 for both of parameters). Therefore there is no 554 interaction (additive effect) between the MMR and sCT content parameters affecting the 555 release properties of the NPs. 556 electrostatic type of interactions between components and high solubility of the HA/sCT 558 complex, compared with other delivery systems capable of providing the release of proteins 559 for days (Corrigan and Li, 2009 ). Most likely, dissolution of NPs with concomitant release of 560 the peptide occurs due to the high ionic strength of the release medium (PBS) with a 561 contribution of sCT diffusion based of the concentration gradient. Fig. 9 and Table 3 show 562 that less than 100% sCT was released from NPs in 24 h and it can be assumed that this 563 amount of sCT remained complexed to HA. Differences is the amount of sCT released are 564 seen for the various HA257/CS systems as described above in contrast to HA/protamine/sCT 565 NPs (Umerska et al., 2014) , where all systems studied had similar properties and released 566 approximately 50% of the peptide in PBS after 1 hour of the studies. Therefore, when a 567 slower peptide release is required, HA257/CS NPs might be a better formulation choice. 568
Stability studies of HA257/CS/sCT NPs 569
It is of importance to ensure that association of the drug with the NPs is unchanging 570 upon storage and that degradation of the active does not occur prior to the conversion into a 571 solid formulation, a more stable pharmaceutical format (Abdelwahed et al., 2006) . No 572 presence of non-associated/released sCT was observed after 1, 2 or 3 days of incubation, 573 neither at 4 ºC, nor at room temperature (RT) or 37 ºC (Table 4 ), indicating that the sCT/NPs 574 were stable in terms of peptide association. No major changes in the particle size, zeta 575 potential and transmittance values were observed upon three days of storage, with the particle 576 size increasing by ~4% for the batch stored at RT and at 37 ºC and transmittance values of 577 the batch stored at 37 ºC decreasing on average by 11% (Table 4) . However, PDI values of 578 the sample changed by more than 10% on day three (storage at 4 and 20 ºC), suggesting that 579 it is best to process the dispersions into powders within 48 h. 580 isoelectric point (IEP) of the particles (Umerska et al., 2012) . The IEP values of HA257/CS 582 NPs (MMR=5 and TPC=1 mg/ml) containing different amounts of sCT (0.1, 0.2 and 0.5 583 mg/ml) was 2.42±0.07, 2.56±0.42 and 2.52±0.54, respectively. These values did not differ 584 significantly from the IEP of the reference formulation without sCT (IEP=2.47±0.25, 585
Umerska et al., 2012). These results suggest that sCT-loaded NPs are not expected to be 586 physically stable at low pH values, however they are likely to remain intact when 587 administered to the joints, as pH of synovial fluid is around 7 (Cummings and Nordby, 1996) . 588 589
Summary and conclusions 590
This work shows that sCT is able to complex to HA via electrostatic interactions and 591 that evidence for hydrophobic interactions between sCT and HA as well as sCT and CS can 592 be inferred from infrared studies. The sCT and HA complex is soluble but, depending on the 593 charge mixing ratio between sCT and HA, the formation of NPs and MPs was observed 594 supporting the hypothesis of sCT/HA system exhibiting associative phase separation. 595
Ternary systems at the nanoscale comprising sCT, HA and CS were successfully 596 developed and characterised, a further development of previously presented binary HA/CS 597 systems (Umerska et al., 2012) . The presence of all three components in these ternary 598 systems was confirmed by FTIR, peptide loading and release studies. The NPs were 599 spontaneously formed in mild conditions in a simple process of mixing aqueous 600 polyelectrolyte solutions at room temperature, without addition of any organic solvents 601 and/or surfactants. The negatively charged HA257/CS/sCT NPs were characterised by very 602 high values of peptide association, being all above 90% for the systems tested. Also, high 603 sCT loading up to 50% (w/w) were achieved. The loading capacity was dependent on the 604 composition of the NPs and increased with an increase in HA content in NPs. The sCT/NPswere capable of providing a rapid release of sCT and modulation of peptide release was 606 observed depending on the NP composition. 607
The presence of sCT in the NPs changed their physical properties when compared to 608 the systems without sCT. The zeta potential of the particles increased due to the presence of 609 sCT, however the particle size was found to be in general smaller for sCT/NPs. 610 HA257/CS/sCT NPs had the hydrodynamic diameters ranging 150-230 nm, what makes them 611 one of the smallest sCT NPs described so far. Moreover, short-term storage physical stability 612 studies in liquid dispersions showed that the physical properties of the particles did not 613 change and no leakage of sCT was observed for up to 3 days. In conclusion, the 614 HA257/CS/sCT systems may be deemed as a suitable nanoparticulate carrier for the delivery 615 of sCT. Table 2 . Table 2 Association efficiency (AE) and sCT loading of HA257/CS/sCT NPs. Samples S12, S14 and S15 aggregated in the liquid and were not further analysed (N/A -data not available). TPC -total polysaccharide concentration, n Time (h) S5 S6 S7 S8 S9 S10 S11 S13
